Atossa Genetics EBIT Margin 2012-2025 | ATOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Atossa Genetics ebit margin from 2012 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Atossa Genetics ebit margin from 2012 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$183.1B
Intuitive Surgical (ISRG)	$172.9B
IDEXX Laboratories (IDXX)	$53.1B
Edwards Lifesciences (EW)	$45.6B
Alcon (ALC)	$42.7B
IQVIA Holdings (IQV)	$32.3B
DexCom (DXCM)	$31.4B
Mettler-Toledo (MTD)	$27.3B
STERIS (STE)	$24.3B
Waters (WAT)	$17.7B
SONOVA HOLDING (SONVY)	$16.7B
Hologic (HOLX)	$15.3B
Penumbra (PEN)	$10B
Sysmex ADR (SSMXY)	$8.7B
Globus Medical (GMED)	$8.5B
Masimo (MASI)	$8.5B
Teleflex (TFX)	$5.4B
Glaukos (GKOS)	$5.3B
TransMedics (TMDX)	$4.5B
Integer Holdings (ITGR)	$3.8B
LivaNova (LIVN)	$2.9B
Veracyte (VCYT)	$2.4B
Alphatec Holdings (ATEC)	$2.3B
PROCEPT BioRobotics (PRCT)	$2.2B
Artivion (AORT)	$2.1B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$1.9B
Pulse Biosciences (PLSE)	$1.1B
Integra LifeSciences Holdings (IART)	$1.1B
Paragon 28 (FNA)	$1.1B